Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tumescent anesthesia for pain in photodynamic therapy for actinic keratosis
NCT04779255Unknown
- Sponsor
- CHU de Poitiers
- Start
- Jul 2021
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of lidocaine in pain, sponsored by CHU de Poitiers. Primary endpoint: Pain Intensity Measure at 8 months. Status: unknown.
02
Drugs
lidocaine
03
Conditions
pain
Beyond the preview
Go deeper on NCT04779255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04779255.